Market Research Logo

Biosimulation Market by Product (Software, Molecular Simulation, In House, Contract Services), Application (Clinical Trials, PKPD, ADME), Delivery (Subscription, Ownership), End User (Biotech, Pharma Companies, CROs, Regulatory) - Global Forecast to 2022

Biosimulation Market by Product (Software, Molecular Simulation, In House, Contract Services), Application (Clinical Trials, PKPD, ADME), Delivery (Subscription, Ownership), End User (Biotech, Pharma Companies, CROs, Regulatory) - Global Forecast to 2022

“Global biosimulation market projected to grow at a CAGR of 15.9%”
The biosimulation market is expected to reach USD 2.88 billion by 2022 from USD 1.38 billion in 2017, at a CAGR of 15.9%. Increase in R&D investments in the pharmaceutical and biotechnology industries, growing adoption of biosimulation software by regulatory bodies, technologically advanced QSP systems, need to curtail drug discovery and development costs, and growth in the biologics and biosimilars markets are driving the growth of the biosimulation market. On the other hand, market growth may be limited to a certain extent due to the lack of standardization for biosimulation solutions.

“Biosimulation services are expected to grow at the highest CAGR during the forecast period”
By product and service, the biosimulation market is segmented into software and services. The biosimulation services segment is projected to register the highest CAGR during the forecast period. The high growth in this segment is attributed to the recurring need for services such as data analysis, and consulting services.

“Ownership models segment is expected to dominate the market during the forecast period”
Based on the delivery model, the biosimulation market is segmented into ownership models and subscription models. The ownership models segment is expected to dominate the market during the forecast period. Buyers mainly opt for these delivery models due to the security benefits associated with them are the major factors that are supporting the growth of this delivery models segment.

“Europe to witness high growth during the forecast period”
In 2017, North America is expected to account for the largest share of the market followed by Europe. However, Europe is expected to register the highest CAGR during the forecast period. The growing focus on research-related funding activities by governments is expected to assist in the development of drug discovery and development process, thus driving the demand for biosimulation in the European region.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 62%; Tier 2 - 25%; Tier 3 - 13%.
• By Designation: C-level- 29%; D-level- 25%; Others-46%.
• By Region: North America-55%; Europe-24%; Asia-15%; RoW-6%.

List of companies profiled in the report
• Certara (US)
• Simulations Plus (US)
• Dassault Systèmes (France)
• Schrödinger (US)
• ACD/Labs (Canada)
• Chemical Computing Group (Canada)
• Physiomics (UK)
• Evidera (US)
• In silico biosciences (US)
• INOSIM Software (Germany)
• Insilico Biotechnology (Germany)
• LeadInvent Technologies (India)
• Rosa (US)
• Nuventra Pharma (US)
• Genedata (Switzerland)ssss

Research Coverage:
The report provides an overview of the biosimulation market. It aims at estimating the market size and future growth potential of this market across different segments such as product & service, applications, delivery model, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall biosimulation market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • MARKET STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
    • SECONDARY DATA
      • SECONDARY SOURCE
    • PRIMARY DATA
      • PRIMARY SOURCES
      • KEY INDUSTRY INSIGHTS
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • BIOSIMULATION MARKET OVERVIEW
    • BIOSIMULATION SOFTWARE MARKET, BY TYPE
    • GEOGRAPHIC ANALYSIS: BIOSIMULATION MARKET IN EUROPE, BY END USER AND COUNTRY
    • BIOSIMULATION DRUG DEVELOPEMENT MARKET, BY TYPE
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
      • RESTRAINT
      • OPPORTUNITIES
      • CHALLENGES
  • BIOSIMULATION MARKET, BY PRODUCT & SERVICE
    • INTRODUCTION
      • Table BIOSIMULATION MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
    • SOFTWARE
      • Table BIOSIMULATION SOFTWARE MARKET, BY TYPE, 2015-2022 (USD MILLION)
      • Table BIOSIMULATION SOFTWARE MARKET, BY REGION, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMULATION SOFTWARE MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
      • Table EUROPE: BIOSIMULATION SOFTWARE MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
      • PK/PD MODELING AND SIMULATION SOFTWARE
        • Table PK/PD MODELING AND SIMULATION SOFTWARE MARKET, BY REGION, 2015-2022 (USD MILLION)
        • Table NORTH AMERICA: PK/PD MODELING AND SIMULATION SOFTWARE MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
        • Table EUROPE: PK/PD MODELING AND SIMULATION SOFTWARE MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
      • MOLECULAR MODELING AND SIMULATION SOFTWARE
        • Table MOLECULAR MODELING AND SIMULATION SOFTWARE MARKET, BY REGION, 2015-2022 (USD MILLION
        • Table NORTH AMERICA: MOLECULAR MODELING AND SIMULATION SOFTWARE MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
        • Table EUROPE: MOLECULAR MODELING AND SIMULATION SOFTWARE MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
      • PBPK MODELING AND SIMULATION SOFTWARE
        • Table PBPK MODELING AND SIMULATION SOFTWARE MARKET, BY REGION, 2015-2022 (USD MILLION)
        • Table NORTH AMERICA: PBPK MODELING AND SIMULATION SOFTWARE MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
        • Table EUROPE: PBPK MODELING AND SIMULATION SOFTWARE MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
      • TOXICITY PREDICTION SOFTWARE
        • Table TOXICITY PREDICTION SOFTWARE MARKET, BY REGION, 2015-2022 (USD MILLION)
        • Table NORTH AMERICA: TOXICITY PREDICTION SOFTWARE MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
        • Table EUROPE: TOXICITY PREDICTION SOFTWARE MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
      • TRIAL DESIGN SOFTWARE
        • Table TRIAL DESIGN SOFTWARE MARKET, BY REGION, 2015-2022 (USD MILLION)
        • Table NORTH AMERICA: TRIAL DESIGN SOFTWARE MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
        • Table EUROPE: TRIAL DESIGN SOFTWARE MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
      • OTHER BIOSIMULATION SOFTWARE
        • Table OTHER BIOSIMULATION SOFTWARE MARKET, BY REGION, 2015-2022 (USD MILLION)
        • Table NORTH AMERICA: OTHER BIOSIMULATION SOFTWARE MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
        • Table EUROPE: OTHER BIOSIMULATION SOFTWARE MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
    • SERVICES
      • Table BIOSIMULATION SERVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
      • Table BIOSIMULATION SERVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMULATION SERVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
      • Table EUROPE: BIOSIMULATION SERVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
      • IN-HOUSE SERVICES
        • Table IN-HOUSE BIOSIMULATION SERVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
        • Table NORTH AMERICA: IN-HOUSE BIOSIMULATION SERVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
        • Table EUROPE: IN-HOUSE BIOSIMULATION SERVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
      • CONTRACT SERVICES
        • Table CONTRACT BIOSIMULATION SERVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
        • Table NORTH AMERICA: CONTRACT BIOSIMULATION SERVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
        • Table EUROPE: CONTRACT BIOSIMULATION SERVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • BIOSIMULATION MARKET, BY APPLICATION
    • INTRODUCTION
      • Table BIOSIMULATION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
    • DRUG DEVELOPMENT
      • Table BIOSIMULATION MARKET FOR DRUG DEVELOPMENT, BY TYPE, 2015-2022 (USD MILLION)
      • Table BIOSIMULATION MARKET FOR DRUG DEVELOPMENT, BY REGION, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMULATION MARKET FOR DRUG DEVELOPMENT, BY COUNTRY, 2015-2022 (USD MILLION)
      • Table EUROPE: BIOSIMULATION MARKET FOR DRUG DEVELOPMENT, BY COUNTRY, 2015-2022 (USD MILLION)
      • PRECLINICAL TESTING
        • Table BIOSIMULATION MARKET FOR PRECLINICAL TESTING, BY TYPE, 2015-2022 (USD MILLION)
        • Table BIOSIMULATION MARKET FOR PRECLINICAL TESTING, BY REGION, 2015-2022 (USD MILLION )
        • Table NORTH AMERICA: BIOSIMULATION MARKET FOR PRECLINICAL TESTING, BY COUNTRY, 2015-2022 (USD MILLION)
        • Table EUROPE: BIOSIMULATION MARKET FOR PRECLINICAL TESTING, BY COUNTRY, 2015-2022 (USD MILLION)
        • Table BIOSIMULATION MARKET FOR PK/PD, BY REGION, 2015-2022 (USD MILLION)
        • Table NORTH AMERICA: BIOSIMULATION MARKET FOR PK/PD, BY COUNTRY, 2015-2022 (USD MILLION)
        • Table EUROPE: BIOSIMULATION MARKET FOR PK/PD, BY COUNTRY, 2015-2022 (USD MILLION)
        • Table BIOSIMULATION MARKET FOR ADME/TOX, BY REGION, 2015-2022 (USD MILLION)
        • Table NORTH AMERICA: BIOSIMULATION MARKET FOR ADME/TOX, BY COUNTRY, 2015-2022 (USD MILLION)
        • Table EUROPE: BIOSIMULATION MARKET FOR ADME/TOX, BY COUNTRY, 2015-2022 (USD MILLION)
      • CLINICAL TRIALS
        • Table BIOSIMULATION MARKET FOR CLINICAL TRIALS, BY REGION, 2015-2022 (USD MILLION)
        • Table NORTH AMERICA: BIOSIMULATION MARKET FOR CLINICAL TRIALS, BY COUNTRY, 2015-2022 (USD MILLION)
        • Table EUROPE: BIOSIMULATION MARKET FOR CLINICAL TRIALS, BY COUNTRY, 2015-2022 (USD MILLION)
    • DRUG DISCOVERY
      • Table BIOSIMULATION MARKET FOR DRUG DISCOVERY, BY TYPE, 2015-2022 (USD MILLION )
      • Table BIOSIMULATION MARKET FOR DRUG DISCOVERY, BY REGION, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMULATION MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2015-2022 (USD MILLION)
      • Table EUROPE: BIOSIMULATION MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2015-2022 (USD MILLION)
      • TARGET IDENTIFICATION AND VALIDATION
        • Table BIOSIMULATION MARKET FOR TARGET IDENTIFICATION AND OPTIMIZATION, BY REGION, 2015-2022 (USD MILLION)
        • Table NORTH AMERICA: BIOSIMULATION MARKET FOR TARGET IDENTIFICATION AND VALIDATION, BY COUNTRY, 2015-2022 (USD MILLION)
        • Table EUROPE: BIOSIMULATION MARKET FOR TARGET IDENTIFICATION AND VALIDATION, BY COUNTRY, 2015-2022 (USD MILLION)
      • LEAD IDENTIFICATION AND OPTIMIZATION
        • Table BIOSIMULATION MARKET FOR LEAD IDENTIFICATION AND OPTIMIZATION, BY REGION, 2015-2022 (USD MILLION)
        • Table NORTH AMERICA: BIOSIMULATION MARKET FOR LEAD IDENTIFICATION AND OPTIMIZATION, BY COUNTRY, 2015-2022 (USD MILLION)
        • Table EUROPE: BIOSIMULATION MARKET FOR LEAD IDENTIFICATION AND OPTIMIZATION, BY COUNTRY, 2015-2022 (USD MILLION)
    • OTHER APPLICATIONS
      • Table BIOSIMULATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2015-2022 (USD MILLION )
      • Table NORTH AMERICA: BIOSIMULATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
      • Table EUROPE: BIOSIMULATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • BIOSIMULATION MARKET, BY DELIVERY MODEL
    • INTRODUCTION
      • Table GLOBAL BIOSIMULATION MARKET, BY DELIVERY MODEL, 2015-2022 (USD MILLION)
    • SUBSCRIPTION MODELS
      • Table GLOBAL BIOSIMULATION MARKET FOR SUBSCRIPTION MODELS, BY REGION, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMULATION MARKET FOR SUBSCRIPTION MODELS, BY COUNTRY, 2015-2022 (USD MILLION)
      • Table EUROPE: BIOSIMULATION MARKET FOR SUBSCRIPTION MODELS, BY COUNTRY, 2015-2022 (USD MILLION)
    • OWNERSHIP MODELS
      • Table GLOBAL BIOSIMULATION MARKET FOR OWNERSHIP MODELS, BY REGION, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMULATION MARKET FOR OWNERSHIP MODELS, BY COUNTRY, 2015-2022 (USD MILLION)
      • Table EUROPE: BIOSIMULATION MARKET FOR OWNERSHIP MODELS, BY COUNTRY, 2015-2022 (USD MILLION)
  • BIOSIMULATION MARKET, BY END USER
    • INTRODUCTION
      • Table BIOSIMULATION MARKET, BY END USER, 2015-2022 (USD MILLION)
    • PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
      • Table BIOSIMULATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMULATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2015-2022 (USD MILLION)
      • Table EUROPE: BIOSIMULATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2015-2022 (USD MILLION)
    • RESEARCH INSTITUTES
      • Table BIOSIMULATION MARKET FOR RESEARCH INSTITUTES, BY REGION, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMULATION MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2015-2022 (USD MILLION)
      • Table EUROPE: BIOSIMULATION MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2015-2022 (USD MILLION)
    • CONTRACT RESEARCH ORGANIZATIONS
      • Table BIOSIMULATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMULATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
      • Table EUROPE: BIOSIMULATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
    • REGULATORY AUTHORITIES
      • Table BIOSIMULATION MARKET FOR REGULATORY AUTHORITIES, BY REGION, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMULATION MARKET FOR REGULATORY AUTHORITIES, BY COUNTRY, 2015-2022 (USD MILLION)
      • Table EUROPE: BIOSIMULATION MARKET FOR REGULATORY AUTHORITIES, BY COUNTRY, 2015-2022 (USD MILLION)
    • OTHER END USERS
      • Table BIOSIMULATION MARKET FOR OTHER END USERS, BY REGION, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMULATION MARKET FOR OTHER END USERS, BY COUNTRY, 2015-2022 (USD MILLION)
      • Table EUROPE: BIOSIMULATION MARKET FOR OTHER END USERS, BY COUNTRY, 2015-2022 (USD MILLION)
  • BIOSIMULATION MARKET, BY REGION
    • INTRODUCTION
      • Table BIOSIMULATION MARKET, BY REGION, 2015-2022 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA BIOSIMULATION MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMULATION MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMULATION SOFTWARE MARKET, BY TYPE, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMULATION SERVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMULATION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMULATION MARKET FOR DRUG DEVELOPMENT APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMULATION MARKET FOR PRECLINICAL TESTING, BY TYPE, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMULATION MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMULATION MARKET, BY DELIVERY MODEL, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMULATION MARKET, BY END USER, 2015-2022 (USD MILLION)
      • US
        • Table US: BIOSIMULATION MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
        • Table US: BIOSIMULATION SOFTWARE MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table US: BIOSIMULATION SERVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table US: BIOSIMULATION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
        • Table US: BIOSIMULATION MARKET FOR DRUG DEVELOPMENT APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table US: BIOSIMULATION MARKET FOR PRECLINICAL TESTING, BY TYPE, 2015-2022 (USD MILLION)
        • Table US: BIOSIMULATION MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table US: BIOSIMULATION MARKET, BY DELIVERY MODEL, 2015-2022 (USD MILLION)
        • Table US: BIOSIMULATION MARKET, BY END USER, 2015-2022 (USD MILLION)
      • CANADA
        • Table CANADA: BIOSIMULATION MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
        • Table CANADA: BIOSIMULATION SOFTWARE MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table CANADA: BIOSIMULATION SERVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table CANADA: BIOSIMULATION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
        • Table CANADA: BIOSIMULATION MARKET FOR DRUG DEVELOPMENT APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table CANADA: BIOSIMULATION MARKET FOR PRECLINICAL TESTING, BY TYPE, 2015-2022 (USD MILLION)
        • Table CANADA: BIOSIMULATION MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table CANADA: BIOSIMULATION MARKET, BY DELIVERY MODEL, 2015-2022 (USD MILLION)
        • Table CANADA: BIOSIMULATION MARKET, BY END USER, 2015-2022 (USD MILLION)
    • EUROPE
      • Table EUROPE: PHARMACEUTICAL R&D EXPENDITURE, BY COUNTRY, 2015
      • Table EUROPE: BIOSIMULATION MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
      • Table EUROPE: BIOSIMULATION MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
      • Table EUROPE: BIOSIMULATION SOFTWARE MARKET, BY TYPE, 2015-2022 (USD MILLION)
      • Table EUROPE: BIOSIMULATION SERVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
      • Table EUROPE: BIOSIMULATION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
      • Table EUROPE: BIOSIMULATION MARKET FOR DRUG DEVELOPMENT APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
      • Table EUROPE: BIOSIMULATION MARKET FOR PRECLINICAL TESTING, BY TYPE, 2015-2022 (USD MILLION)
      • Table EUROPE: BIOSIMULATION MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
      • Table EUROPE: BIOSIMULATION MARKET, BY DELIVERY MODEL, 2015-2022 (USD MILLION)
      • Table EUROPE: BIOSIMULATION MARKET, BY END USER, 2015-2022 (USD MILLION)
      • GERMANY
        • Table BIOTECHNOLOGY INDUSTRY IN GERMANY (2009 VS. 2016)
        • Table GERMANY: BIOSIMULATION MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
        • Table GERMANY: BIOSIMULATION SOFTWARE MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table GERMANY: BIOSIMULATION SERVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table GERMANY: BIOSIMULATION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
        • Table GERMANY: BIOSIMULATION MARKET FOR DRUG DEVELOPMENT APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table GERMANY: BIOSIMULATION MARKET FOR PRECLINICAL TESTING, BY TYPE, 2015-2022 (USD MILLION)
        • Table GERMANY: BIOSIMULATION MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table GERMANY: BIOSIMULATION MARKET, BY DELIVERY MODEL, 2015-2022 (USD MILLION)
        • Table GERMANY: BIOSIMULATION MARKET, BY END USER, 2015-2022 (USD MILLION)
      • UK
        • Table UK: BIOSIMULATION MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
        • Table UK: BIOSIMULATION SOFTWARE MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table UK: BIOSIMULATION SERVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table UK: BIOSIMULATION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
        • Table UK: BIOSIMULATION MARKET FOR DRUG DEVELOPMENT APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table UK: BIOSIMULATION MARKET FOR PRECLINICAL TESTING, BY TYPE, 2015-2022 (USD MILLION)
        • Table UK: BIOSIMULATION MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table UK: BIOSIMULATION MARKET, BY DELIVERY MODEL, 2015-2022 (USD MILLION)
        • Table UK: BIOSIMULATION MARKET, BY END USER, 2015-2022 (USD MILLION)
      • FRANCE
        • Table FRANCE: BIOSIMULATION MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
        • Table FRANCE: BIOSIMULATION SOFTWARE MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table FRANCE: BIOSIMULATION SERVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table FRANCE: BIOSIMULATION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
        • Table FRANCE: BIOSIMULATION MARKET FOR DRUG DEVELOPMENT APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table FRANCE: BIOSIMULATION MARKET FOR PRECLINICAL TESTING, BY TYPE, 2015-2022 (USD MILLION)
        • Table FRANCE: BIOSIMULATION MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table FRANCE: BIOSIMULATION MARKET, BY DELIVERY MODEL, 2015-2022 (USD MILLION)
        • Table FRANCE: BIOSIMULATION MARKET, BY END USER, 2015-2022 (USD MILLION)
      • REST OF EUROPE (ROE)
        • Table ROE: BIOSIMULATION MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
        • Table ROE: BIOSIMULATION SOFTWARE MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table ROE: BIOSIMULATION SERVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table ROE: BIOSIMULATION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
        • Table ROE: BIOSIMULATION MARKET FOR DRUG DEVELOPMENT APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table ROE: BIOSIMULATION MARKET FOR PRECLINICAL TESTING, BY TYPE, 2015-2022 (USD MILLION)
        • Table ROE: BIOSIMULATION MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
        • Table ROE: BIOSIMULATION MARKET, BY DELIVERY MODEL, 2015-2022 (USD MILLION)
        • Table ROE: BIOSIMULATION MARKET, BY END USER, 2015-2022 (USD MILLION)
    • ASIA
      • Table ASIA: BIOSIMULATION MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
      • Table ASIA: BIOSIMULATION SOFTWARE MARKET, BY TYPE, 2015-2022 (USD MILLION)
      • Table ASIA: BIOSIMULATION SERVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
      • Table ASIA: BIOSIMULATION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
      • Table ASIA: BIOSIMULATION MARKET FOR DRUG DEVELOPMENT APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
      • Table ASIA: BIOSIMULATION MARKET FOR PRECLINICAL TESTING, BY TYPE, 2015-2022 (USD MILLION)
      • Table ASIA: BIOSIMULATION MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
      • Table ASIA: BIOSIMULATION MARKET, BY DELIVERY MODEL, 2015-2022 (USD MILLION)
      • Table ASIA: BIOSIMULATION MARKET, BY END USER, 2015-2022 (USD MILLION)
    • REST OF THE WORLD (ROW)
      • Table ROW: BIOSIMULATION MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
      • Table ROW: BIOSIMULATION SOFTWARE MARKET, BY TYPE, 2015-2022 (USD MILLION)
      • Table ROW: BIOSIMULATION SERVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
      • Table ROW: BIOSIMULATION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
      • Table ROW: BIOSIMULATION MARKET FOR DRUG DEVELOPMENT APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
      • Table ROW: BIOSIMULATION MARKET FOR PRECLINICAL TESTING, BY TYPE, 2015-2022 (USD MILLION)
      • Table ROW: BIOSIMULATION MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
      • Table ROW: BIOSIMULATION MARKET, BY DELIVERY MODEL, 2015-2022 (USD MILLION)
      • Table ROW: BIOSIMULATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET RANKING ANALYSIS, 2016
      • Table RANK OF COMPANIES IN THE GLOBAL BIOSIMULATION MARKET, 2016
    • COMPETITIVE SCENARIO
      • PRODUCT LAUNCHES AND APPROVALS
        • Table PRODUCT LAUNCHES AND APPROVALS
      • AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
        • Table AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
      • ACQUISITIONS
        • Table ACQUISITIONS
      • EXPANSIONS
        • Table EXPANSIONS
  • COMPANY PROFILES
    • CERTARA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • SWOT ANALYSIS
      • MNM VIEW
    • SIMULATION PLUS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • SWOT ANALYSIS
      • MNM VIEW
    • DASSAULT SYSTÈMES
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • SWOT ANALYSIS
      • MNM VIEW
    • SCHRÖDINGER
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • SWOT ANALYSIS
      • MNM VIEW
    • ADVANCED CHEMISTRY DEVELOPMENT
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • SWOT ANALYSIS
      • MNM VIEW
    • CHEMICAL COMPUTING GROUP
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ROSA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • GENEDATA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • PHYSIOMICS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • EVIDERA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • IN SILICO BIOSCIENCES
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • MNM VIEW
    • LEADINVENT TECHNOLOGIES
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • MNM VIEW
    • INOSIM SOFTWARE
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • MNM VIEW
    • NUVENTRA PHARMA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • MNM VIEW
    • INSILICO BIOTECHNOLOGY
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
  • APPENDIX
    • INSIGHTS FORM INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report